Search results
Results from the WOW.Com Content Network
Rubella virus, scientific name Rubivirus rubellae, is a member of the genus Rubivirus and belongs to the family of Matonaviridae, whose members commonly have a genome of single-stranded RNA of positive polarity which is enclosed by an icosahedral capsid.
Rubella, also known as German measles or three-day measles, [6] is an infection caused by the rubella virus. [3] This disease is often mild, with half of people not realizing that they are infected. [ 1 ] [ 7 ] A rash may start around two weeks after exposure and last for three days. [ 1 ]
With the introduction of the rubella vaccine in 1969, the number of cases of rubella in the United States has decreased 99%, from 57,686 cases in 1969 to 271 cases in 1999. [3] For women who plan to become pregnant, the MMR (measles mumps, rubella) vaccination is highly recommended, at least 28 days prior to conception. [ 17 ]
The 1962–1965 rubella epidemic was an outbreak of rubella across Europe and the United States. [ 1 ] [ 2 ] The Rubella virus, also known as the German measles, is a single-stranded RNA virus from the family Togaviridae and genus Rubivirus . [ 3 ]
The virus is highly contagious and is spread by coughing and sneezing via close personal contact or direct contact with secretions. [52] Measles is the most contagious virus known. [20] It remains infective for up to two hours in that airspace or nearby surfaces.
If you're traveling for the holidays, you're probably feeling a bit worn-down—but is it just fatigue, or could it be COVID-19?. It’s probably been a minute since you last thought about COVID ...
This is an accepted version of this page This is the latest accepted revision, reviewed on 20 December 2024. Combined vaccine against measles, mumps, and rubella Pharmaceutical compound MMR vaccine MMR vaccine Combination of Measles vaccine Vaccine Mumps vaccine Vaccine Rubella vaccine Vaccine Clinical data Trade names M-M-R II, Priorix, Tresivac, others Other names MPR vaccine AHFS / Drugs ...
Rubella vaccine is a vaccine used to prevent rubella. [1] Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for ...